Pulmonology

A rich portfolio of clinical depth – all on a single platform

Kontaktoplysninger

* Dette felt er påkrævet
*
*
*
*
*
*
*
*
*
Forrige
Ved at specificere årsagen for din kontakt vil vi kunne yde dig en bedre service.
*
*
*
Forrige

A comprehensive lung management solution on a single advanced platform

From nodule discovery to diagnosis to therapy monitoring and follow up, the IntelliSpace Portal offers a full suite of tools to help you track Pulmonary disease. The IntelliSpace Portal is an advanced visualization solution that allows you the flexibility to view, analyze, collaborate,
and report seamlessly using consistent workflow tools.
Calcium Scoring

CT Calcium Scoring

One-click 3D calcium segmentation
Rapidly quantifies coronary artery calcifications (CAC) and includes mass, Agatston score, and volume scores. It allows you to distribute automated, customizable reports electronically or on paper.
calcium scoring thumbnail
Benefits
  • One-click 3D segmentation and quantification of coronary artery calcifications (CAC) and includes mass, Agatston, and volume scores.
  • Customized reporting of measurements and calcium scores.
  • Each report is editable and new default templates can be easily created and included in the system configuration.
  • Multi-Ethnic Study of Atherosclerosis (MESA) risk-score is embedded into the workflow, including reporting.
COPD

CT COPD

Track lung disease
CT COPD helps quantifiably track the destructive process of diffuse lung disease (emphysema) and helps localize specific areas of the lung that have been affected.
COPD thumbnail
Benefits
  • Automatically segment both the left and right lungs to determine total lung volume (cc), diseased lung volume (cc) and percentage of affected lung.
  • Segment the airway tree, attain centerlines, and measure airway parameters such as lumen diameter and wall thickness.
Lung Nodule Assessment (LNA)

CT Lung Nodule Assessment (LNA)

For diagnostic use and low-dose CT lung cancer screening
An advanced imaging package for the segmentation, quantification and follow-up of physician-indicated lung nodules, that can be used in both diagnostic and screening evaluations, supporting Low Dose CT Lung Cancer Screening.*
 lung nodule assessment thumbnail
Benefits
  • One-click volume segmentation with advanced reporting tools to allow efficiently export results in various formats while supporting LungRADS categorization.
  • Workflow and decision support tools streamline follow-up readings, together with a Risk Calculator tool based on patient and nodule characteristics for estimation of the probability that lung nodules detected on baseline screening low-dose CT scans are malignant.
  • 2017 Fleischner criteria for incidental findings.
  • Features pre-filled data including characteristics for each nodule in configurable presets.
*The screening must be performed within the established inclusion criteria of programs/protocols that have been approved and published by either a governmental body or professional medical society. Please refer to clinical literature, including the results of the National Lung Screening Trial (N Engl J Med 2011; 365:395-409) and subsequent literature, for further information. Some functionalities may not be available in all territories. Please contact Philips representative for more details.
Lung Nodule CAD

CT Lung Nodule CAD*

Rely on an artificial second reader

Computer-aided detection system for chest multi-slice CT exams

Artificial second reader to support in detection of lesions or nodules which may have been missed.
lung nodule cad thumbnail
Benefits
  • Automatically

- detect potentially actionable lung nodules – not just round objects or ROIs

- correlate 2D, 3D, and lung maps

- register current and prior nodules

- calculate nodule changes

 

  • Exclude normal anatomy with volumetric segmentation and detect nodules based on size, shape, density, and anatomical context.
  • Includes growth report and one-click display of all CAD findings.
*CAD functionality not available for sale in the US.
Pulmonary Artery Analysis (PAA)

CT Pulmonary Artery Analysis (PAA)

Guided pulmonary embolism discovery
CT Pulmonary Artery Analysis (PAA) offers automatic segmentation of pulmonary arteries on MDCT data to estimate the patency of pulmonary arteries.
pulmonary artery analysis thumbnail
Benefits
  • A full suite of tools helps you visualize the lungs, review results, and report any PE findings. Extract relevant cardiac measurements such as RV/LV ventricular ratio and chambers volumes.
Spectral Light Magic Glass

CT Spectral Light Magic Glass

Allows retrospective use of spectral data that was saved as an SBI. Allows reviewing of spectral data and identification of most relevant result to be launched into the conventional CT application for routine work – even for applications that were not developed to support Spectral functionality.
spectral light magic glass thumbnail
Benefits
  • Allows reviewing of spectral data and identification of most relevant result to be launched into the conventional CT application for routine work – even for applications that were not developed to support Spectral functionality:

- Virtual Colonoscopy application

- Liver application

- Trauma Viewer (Acute Multifunctional Review)

- TAVI application

- PAA application

- Brain Perfusion application

- Functional CT (FCT) application.

Spectral Magic Glass on PACS

CT Spectral Magic Glass on PACS*

IQon Spectral CT Functionality
IQon Spectral CT is the only scanner to offer CT Spectral Light Magic Glass and CT Spectral Magic Glass on PACS, helping radiologists review and analyze multiple layers of spectral data at once, including on their PACS.
spectral magic glass on pacs thumbnail
Benefits
  • On-demand simultaneous analysis of multiple spectral results for an Region Of Interest (ROI).
  • Integrates into a health system’s current PACS setup for certain PACS vendors.
  • Spectral results viewable, during a routine reading.
  • Enterprise-wide spectral viewing and analysis allows access to capabilities virtually anywhere in the organization.
* Standard with the CT Spectral option on IntelliSpace Portal.
Spectral Viewer

CT Spectral Viewer

IQon Spectral CT* Functionality
The spectral viewer is optimized for analysis of spectral data sets from the IQon Spectral CT Scanner. Obtain a comprehensive overview of each patient quickly and easily, quantify quickly, and assist in diagnosis. It is designed to accommodate general spectral viewing needs with additional tools to assist in CT images analysis.
spectral viewer thumbnail
Benefits
  • Enhances the conventional image by overlaying an iodine map.
  • Visualization of virtual non-contrast images.
  • Images at different energy levels (40-200 keV).
  • Switching to various spectral results can be done through a viewport control.
  • Manage presets to create user/site-specific presets.
  • Lesion characterization using scatter plots.
  • Tissue characterization using attenuation curves.
* IQon CT reconstruction provides a single DICOM entity containing sufficient information for retrospective analysis - Spectral Base Image (SBI). SBI contains all the spectrum of spectral results with no need for additional reconstruction or post-processing. Spectral applications are creating different spectral results from SBI.
Tumor Tracking

Multi Modality Tumor Tracking (MMTT)

Streamlined workflow for follow up and analysis of oncology patients
Multi Modality Tumor Tracking (MMTT) is a post processing software used to monitor disease state and assess treatment response.
tumor tracking thumbnail
Benefits
  • The application is used to display, process, analyze, quantify and manipulate anatomical and functional images for CT, MR, PET/CT and SPECT/CT images and/or multiple time-points.
  • Offers enhanced semi-automatic volumetric segmentation, as well as selectable oncology response criteria including standards such as RECIST 1.0, RECIST 1.1, WHO, CHOI, PERCIST, irRC and mRECIST.
  • A quantitative overview of volumetric and functional features is organized for quick navigation.
  • The application also includes Glucose SUV, an option to calculate lesion uptake normalized by patient glucose level, as well as PET metabolic volume segmentation options based on percentage.

Kontaktoplysninger

* Dette felt er påkrævet
*
*
*
*
*
*
*
*
*
Forrige
Ved at specificere årsagen for din kontakt vil vi kunne yde dig en bedre service.
*
*
Forrige